Satellite Banner
Technology Networks Header
Sunday, October 26, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Ion Source Technology for GC-MS Launched at Pittcon 2014
Saturday, February 22, 2014
New Select-eV technology showcased at Pittcon 2014 from March 2-6 in Chicago.

IONICON Launches the New Super-Fast PTR-TOF 1000 Trace Gas Analyzer
Wednesday, February 19, 2014
The smallest, lightest and most affordable time of flight based PTR-MS ever developed.

Rugged Direct Sample Analysis by Mass Spectrometry with the DART®-QS Source
Monday, February 17, 2014
Rapid analysis with the Direct Analysis in Real Time technology provides near-instantaneous detection of drugs of abuse and contaminants.

Protea Announces Release of New Gel Protein Recovery System
Thursday, February 13, 2014
The Gel Protein Recovery GPR-850 System enables intact protein recovery from polyacrylamide gels for top-down proteomics applications.

Waters Introduces UPLC System for nano- to Microscale Separations
Wednesday, January 29, 2014
New UPLC system and columns drive separations efficiency and the sensitivity of LC-MS analyses to new levels.

Biotage Announces the Launch of ISOLUTE® PLD+
Monday, January 27, 2014
Improved sensitivity with the new protein and phospholipid removal plate.

Shimadzu Announces Product Launches, Presentations and Poster Sessions for Pittcon
Thursday, January 23, 2014
SSI at Pittcon 2014 conference and exhibition, March 2-6, at McCormick Place in Chicago.

Vacuum Process Gas Analyzer
Thursday, January 23, 2014
Compact HPR-30 differentially-pumped mass spectrometer from Hiden.

IONICON PTR-MS System Monitors GMP Biotech Processes
Tuesday, January 21, 2014
PTR-MS analyze VOCs in real-time and in very low concentrations.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 1106
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv